Skip to content

Metabolic and vascular adaptations to a positive energy balance

Metabolic and vascular adaptations to a positive energy balance

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22377
Enrollment
8
Registered
2008-10-21
Start date
2008-08-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin resistance, diabetes, obesity and inflammation

Interventions

Based on the eucaloric diet in the run-in phase, a hypercaloric diet will be designed calculated as 1.4 x kcal in the eucaloric diet. The protein, fat and carbohydrate content of the diet will respect

Sponsors

Department of Endocrinology and Metabolism Academic Medical Center, Amsterdam, the Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 30-50 2. normal glucose tolerance (OGTT) 3. Caucasian men 4. normal weight BMI >20 and <25

Exclusion criteria

Exclusion criteria: 1. Age 50 years 2. Frequent intensive exercise (>2 week) or sedentary life style 3. Any medication 4. Lipid disorders, renal insufficiency, elevated liver enzymes 5. Obesity in the past 6. BMI 25 kg/m2 7. Smoking 8. Unstable weight 3 months prior to study inclusion 9. High blood pressure 10. Alcohol abuse (> 3day) 11. Participation in research during the year prior to inclusion

Design outcomes

Primary

MeasureTime frame
- Weight gain and loss - Pro-inflammatory response in adipose tissue and in plasma after initialising a hypercaloric diet - Change in inflammatory response after switching to hypocaloric diet - Insulin sensitivity; Homa-IR and B-cell function - Changes in incretine response in relation to hyper- and hypocaloric diet

Secondary

MeasureTime frame
- Changes in symphatic nervous activity - Glucoregulatory hormones

Contacts

Public ContactM. Brands

Academic Medical Center (AMC) F5-162 Endocrinology and Metabolism

m.brands@amc.uva.nl+31 (0)20 5662663

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)